Epidermal Growth Factor Receptor in Tumor Angiogenesis

Overview

Journal Hematol Oncol Clin North Am

Specialties Hematology
Oncology

Date 2004 Oct 12

PMID 15474332

Citations 66

Authors

Lee M Ellis

Affiliations

Soon will be listed here.

Abstract

This article focuses on the preclinical evidence for activation of the epidermal growth factor receptor (EGFR) in promoting angiogenesis and the efficacy of anti-EGFR agents in inhibiting angiogenesis and tumor growth.

Citing Articles

Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features.

Addisu S, Bekele A, Seifu D, Assefa M, Gemechu T, Hoenerhoff M PLoS One. 2024; 19(10):e0308411.

PMID: 39405290 PMC: 11478813. DOI: 10.1371/journal.pone.0308411.

Development of Novel Class of Phenylpyrazolo[3,4-]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies.

Aljohani A, Zaloa W, Alswah M, Seleem M, Elsebaei M, Bayoumi A Int J Mol Sci. 2023; 24(19).

PMID: 37834474 PMC: 10573254. DOI: 10.3390/ijms241915026.

Role of pelitinib in the regulation of migration and invasion of hepatocellular carcinoma cells via inhibition of Twist1.

Lee S, Kang E, Lee U, Cho S BMC Cancer. 2023; 23(1):703.

PMID: 37495969 PMC: 10373356. DOI: 10.1186/s12885-023-11217-2.

Angiogenic signaling pathways and anti-angiogenic therapy for cancer.

Liu Z, Chen H, Zheng L, Sun L, Shi L Signal Transduct Target Ther. 2023; 8(1):198.

PMID: 37169756 PMC: 10175505. DOI: 10.1038/s41392-023-01460-1.

Dual inhibition of EGFR‑VEGF: An effective approach to the treatment of advanced non‑small cell lung cancer with EGFR mutation (Review).

Wang Q, Zeng A, Zhu M, Song L Int J Oncol. 2023; 62(2).

PMID: 36601768 PMC: 9851127. DOI: 10.3892/ijo.2023.5474.